High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation
Authors
Keywords
-
Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume 10, Issue 8, Pages 1500-1507
Publisher
Wiley
Online
2012-06-09
DOI
10.1111/j.1538-7836.2012.04812.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation
- (2012) Ziad Hijazi et al. CIRCULATION
- The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: Data from the Heart and Soul Study
- (2011) Christine C. Welles et al. AMERICAN HEART JOURNAL
- Bleeding and Stroke Risk in a Real-world Prospective Primary Prevention Cohort of Patients With Atrial Fibrillation
- (2011) Daniela Poli et al. CHEST
- Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study
- (2011) Justin T. Saunders et al. CIRCULATION
- Minor elevations in troponin I are associated with mortality and adverse cardiac events in patients with atrial fibrillation
- (2011) E. J. van den Bos et al. EUROPEAN HEART JOURNAL
- Plasma von Willebrand Factor Levels Are an Independent Risk Factor for Adverse Events Including Mortality and Major Bleeding in Anticoagulated Atrial Fibrillation Patients
- (2011) Vanessa Roldán et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort
- (2011) J. B. OLESEN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study
- (2011) Gregory Lip et al. THROMBOSIS AND HAEMOSTASIS
- High-Sensitivity Troponin T Concentrations in Acute Chest Pain Patients Evaluated With Cardiac Computed Tomography
- (2010) James L. Januzzi et al. CIRCULATION
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPEAN HEART JOURNAL
- Atherothrombosis and atrial fibrillation: Important and often overlapping clinical syndromes
- (2010) Jeremiah Depta et al. THROMBOSIS AND HAEMOSTASIS
- The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?
- (2010) John W. Eikelboom et al. THROMBOSIS AND HAEMOSTASIS
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
- (2009) Gregory Y.H. Lip et al. CHEST
- A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease
- (2009) Torbjørn Omland et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Diagnosis of Myocardial Infarction with Sensitive Cardiac Troponin Assays
- (2009) Tobias Reichlin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation
- (2008) Yi Wan et al.
- Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review
- (2008) John Danesh et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started